Increased Serum Amyloid a as Potential Diagnostic Marker for Lung Cancer: A Meta-Analysis Based on Nine Studies

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2882-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

A Meta-Analysis for CXCR4 as a Prognostic Marker and Potential Drug Target in Non-Small Cell Lung Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2019English

Hepatic Subcapsular Flow as a Significant Diagnostic Marker for Biliary Atresia: A Meta-Analysis

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2020English

Circulating Cell Free DNA as the Diagnostic Marker for Colorectal Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2018English

Association Between Serum Zinc Levels and Lung Cancer: A Meta-Analysis of Observational Studies

World Journal of Surgical Oncology
SurgeryOncology
2019English

Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Elevated Serum Level of Angiopoietin-2 as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

MicroRNA-21 as a Diagnostic Marker for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Pakistan Journal of Medical Sciences
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy